Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-07T15:25:22.188Z Has data issue: false hasContentIssue false

The Cost-effectiveness of Breast Cancer Screening

Published online by Cambridge University Press:  10 March 2009

Petr Skrabanek
Affiliation:
University of Dublin
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © Cambridge University Press 1991

References

1.Ranstam, J. On the validity of case-control studies in the evaluation of screening projects. Presented at Nordisk Cancer-union Breast Cancer Symposium, Lidingä, Norway, 08 17–19, 1989.Google Scholar
2.Roberts, M. M.Breast screening: Time for a rethink. British Medical Journal, 1989, 299, 1153–55.CrossRefGoogle ScholarPubMed
3.Schmidt, J.The epidemiology of mass breast screening — A plea for a valid measure of benefit. Journal of Clinical Epidemiology, 1990, 43, 215–25.CrossRefGoogle ScholarPubMed
4.Skrabanek, P.Benefits of mass breast screening rest on equivocal evidence. Diagnostic Imaging International, 1988, 4(3), 2934.Google Scholar
5.Skrabanek, P.Mass mammography: The time for reappraisal. International Journal of Technology Assessment in Health Care, 1989, 5, 423–30.CrossRefGoogle ScholarPubMed
6.Spratt, J. S., & Spratt, S. W.Medical and legal implications of screening and follow-up procedures for breast cancer. Cancer, 1990, 66, 1351–62.3.0.CO;2-E>CrossRefGoogle ScholarPubMed